UPC CFI 15/2023

Vor dem UPC: Edwards Lifesciences Group (57 Verfahren)·Meril Group (60 Verfahren)

• 2024-11-15
  Infringement ActionÖffentlich

  Zusammenfassung: Munich Local Division full merits decision finding that Meril Life Sciences Pvt Ltd and Meril GmbH infringed Edwards Lifesciences Corporation's patent EP 3 646 825 (a heart valve technology patent). The court ordered a permanent injunction to cease and desist from the infringing acts (transcatheter heart valve products) across all UPC contracting states where the patent has effect, recall of infringing products from commercial channels (excluding devices already scheduled for patient implantation by 15 November 2024), destruction of infringing stock, disclosure of information about distribution and quantities, publication of the decision, and an obligation to pay damages (quantum to be determined separately). The defendant's counterclaim for revocation was dismissed, the patent being upheld as valid. Costs were addressed separately.

  Rechtsfragen anzeigen (7)

  • UPC jurisdiction over pre-June 2023 infringement acts
  • Competence of chosen German local division
  • Bifurcation / referral of revocation counterclaim to Central Division and subsequent stay
  • Scope of injunctive relief under Art. 34 UPCA across all contracting states
  • Third-party interests in corrective measures (Art. 64(4) UPCA)
  • Medical device / patient safety carve-out in recall/destruction orders
  • Damages liability and quantum proceedings
• 2024-09-06
  Infringement ActionÖffentlich

  Zusammenfassung: The Munich Local Division judge-rapporteur issued a procedural order in Edwards Lifesciences v. Meril concerning EP 3 646 825, addressing defendants' arguments that the Central Division Paris first-instance decision on the patent amendment application had failed to consider key invalidity arguments. The judge-rapporteur referred the matter to the full panel, noting that the appeal proceedings before the Court of Appeal would address the alleged deficiencies in the Paris decision.

  Rechtsfragen anzeigen (4)

  • Sufficiency of reasoning in first-instance decision (right to be heard)
  • Referral to full panel (R. 102.1 RoP)
  • Invalidity arguments not addressed in Paris Central Division decision
  • Counterclaim for revocation
• 2023-09-29
  Infringement ActionÖffentlich

  Zusammenfassung: The Munich Local Division issued a procedural order setting out requirements for using official CMS forms and workflows, and clarifying that a security for costs application under Rule 158.1 RoP requires demonstration that the opposing party's financial circumstances give reason to fear a cost order cannot be enforced.

  Rechtsfragen anzeigen (3)

  • Security for costs (Rule 158.1 RoP)
  • CMS workflows (Rule 4.1 RoP)
  • Admissibility of applications
• 2023-08-23
  Infringement ActionÖffentlich

  Zusammenfassung: The Munich Local Division addressed Meril GmbH's request to align deadline for filing the preliminary objection with the deadline running for co-defendant Meril Life Sciences, granting a moderate extension while noting that alignment can also be achieved by shortening later deadlines.

  Rechtsfragen anzeigen (3)

  • Deadline alignment for co-defendants
  • Deadline extension Rule 9.3 RoP
  • CMS access issues
• 2023-08-10
  Infringement ActionÖffentlich

  Zusammenfassung: The Munich Local Division granted Meril GmbH's deadline extension request for filing a preliminary objection, allowing harmonisation of deadlines across co-defendants given service issues and CMS access problems encountered in the early days of the UPC.

  Rechtsfragen anzeigen (3)

  • Deadline extension Rule 9.3 RoP
  • CMS access issues
  • Harmonisation of deadlines for co-defendants